When you’re diagnosed with breast cancer, one of the biggest questions is often: “What is the risk that my cancer could come back?” The answer is not always straightforward and two breast cancers that appear very similar based on size, stage, or even subtype can behave very differently over time. This is where genomic recurrence […]

For many patients diagnosed with hormone receptor-positive breast cancer, anastrozole is a cornerstone of treatment — and understanding its effects matters from day one. Anastrozole belongs to a class of drugs called aromatase inhibitors, which work by blocking the enzyme responsible for converting androgens into estrogen. Reducing estrogen levels helps slow or stop the growth […]

A study published last week in the Journal of the National Cancer Institute reported on the results of the KARISMA trial. The trial results showed promise for (Z)-endoxifen, a tamoxifen metabolite, as an alternative to the popular tamoxifen treatment (but with fewer side effects) due to its ability to reduce breast density. A reduction in […]

Today’s breast cancer trials aren’t just testing small improvements. Many are exploring entirely new ways to treat cancer, reduce side effects, and personalize care. Understanding what is being studied right now can help you have more informed conversations with your care team and feel more confident about what may be available to you. Clinical trials […]